News tagged with clinical oncology

Personalizing targeted immunotherapy

This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are approved for a variety of cancers, as forecast recently by Drew Pardoll, MD, PhD, in a blog post. There is huge ...

Apr 30, 2015
popularity5 comments 0

Subscribe to rss feed